"With the outbreak of COVID-19, we want to ensure we are ready to care for the most critically ill patients while also meeting your needs. New or previously scheduled appointments may be changed to a video or phone visit so you can stay home and still receive quality care. Most prescriptions can be ordered via mail. Visit our website to schedule a virtual appointment, request mail order for your prescription or send an email to your doctor’s office. Our doctors are postponing elective or non-urgent surgeries and procedures."

During the past decade, Kaiser Permanente-Capitol Hill Medical Center conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 17 clinical trials were completed, i.e. on average, 68% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 12 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente-Capitol Hill Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "SWOG Cancer Research Network" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "NRG Oncology" with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente-Capitol Hill Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 25 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente-Capitol Hill Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (4 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials), "Breast Cancer" (3 trials), "Invasive Breast Carcinoma" (3 trials) and "Anatomic Stage II Breast Cancer AJCC v8" (2 trials). Many other conditions were trialed in "Kaiser Permanente-Capitol Hill Medical Center" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente-Capitol Hill Medical Center" are "Drug" (33 trials), "Other" (32 trials), "Biological" (16 trials), "Procedure" (8 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (12 trials), "Quality-of-Life Assessment" (11 trials), "Paclitaxel" (8 trials), "Questionnaire Administration" (8 trials) and "Docetaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente-Capitol Hill Medical Center" are 30 trials for "All" genders, 8 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente-Capitol Hill Medical Center". undefined are not yet recruiting, 12 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Kaiser Permanente-Capitol Hill Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente-Capitol Hill Medical Center, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".